Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
'I carried my wife's body for an hour and a half' - BBC hears stories of protesters killed in Iran - 2The most effective method to Pick The Right Speakers
- 3What do scientists hope to learn from NASA's historic Artemis 2 moon flyby?
- 4Iran plans new restrictions in overhaul of Strait of Hormuz rules
- 5BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Tributes pour in for James Ransone, 'The Wire' actor who died at 46
- Minneapolis ICE shooting: Woman dies after federal agent opens fire on her vehicle amid immigration crackdown
- Italian court approves extradition to Germany of Ukrainian suspect in Nord Stream pipeline blast
- A hospital discharged a woman in labor. This lawmaker wants change.
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- Don't miss the waxing moon swing by the Beehive star cluster March 27
- Creative Tech Contraptions That Will Work on Your Life
- Relive NASA's historic Artemis 2 launch to the moon in these stunning photos
- Grasping the Course of Evacuation and Extradition in U.S. Migration
